🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Infusion of glucose-dependent insulintropic polypeptide (GIP) receptor anta...
Status
Completed
Location
Clinical Metabolic Physiology
Start Date
2018-12-06
Trial ID
NCT03770910
Treatments Being Tested
Glucose-dependent insulinotropic polypeptide (GIP) is a gut-derived increti...
Status
Completed
Location
Clinical Metabolic Physiology
Start Date
2018-06-12
Trial ID
NCT04792762
Treatments Being Tested
The aim of this study is to investigate the effects of antagonising GIP aft...
Status
Completed
Location
Center for Diabetes Research, Gentofte Hospital
Start Date
2017-08-01
Trial ID
NCT03702660
Treatments Being Tested
This research project aims to investigate the role of endogenous GIP during...
Status
Unknown
Location
Gentofte Hospital
Start Date
2023-05-04
Trial ID
NCT06368752
Treatments Being Tested
Postural tachycardia syndrome (POTS) affects ≈3 million young people, chara...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2023-02-25
Trial ID
NCT05375968
Treatments Being Tested
The present study investigates the postprandial role of endogenous glucose-...
Status
Recruiting
Location
Center for Clinical Metabolic Research
Start Date
2025-05-21
Trial ID
NCT06934473
Treatments Being Tested
The two gut-derived hormones, glucose-dependent insulinotropic polypeptide ...
Status
Completed
Location
Center for Clinical Metabolic Research
Start Date
2022-04-07
Trial ID
NCT05177653
Treatments Being Tested